Scarica l'app Stockscreener
26.45
1.05%
-0.28
Dopo l'orario di chiusura:
26.45
Precedente Chiudi:
$26.73
Aprire:
$26.72
Volume 24 ore:
606.83K
Relative Volume:
0.94
Capitalizzazione di mercato:
$1.19B
Reddito:
$681.75M
Utile/perdita netta:
$70.47M
Rapporto P/E:
18.24
EPS:
1.45
Flusso di cassa netto:
$173.19M
1 W Prestazione:
-0.82%
1M Prestazione:
+17.35%
6M Prestazione:
+12.51%
1 anno Prestazione:
+80.18%
Intervallo 1D:
$26.23
$26.94
Intervallo di 1 settimana:
$26.23
$27.64
Portata 52W:
$12.61
$27.98
Pacira Biosciences Inc Stock (PCRX) Company Profile
Nome
Pacira Biosciences Inc
Settore
Telefono
650-242-8052
Indirizzo
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Confronta PCRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PCRX
Pacira Biosciences Inc
|
26.45 | 1.20B | 681.75M | 70.47M | 173.19M | 1.45 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-25 | Aggiornamento | Truist | Hold → Buy |
| 2025-01-30 | Aggiornamento | Truist | Sell → Hold |
| 2024-08-13 | Downgrade | Truist | Buy → Sell |
| 2024-08-12 | Downgrade | JP Morgan | Overweight → Underweight |
| 2024-08-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-08-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-08-12 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-07-03 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-03-07 | Ripresa | JP Morgan | Overweight |
| 2023-12-20 | Iniziato | Raymond James | Outperform |
| 2023-08-03 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-01-31 | Ripresa | Wedbush | Outperform |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-01-03 | Ripresa | JP Morgan | Overweight |
| 2021-07-26 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-04-21 | Ripresa | JP Morgan | Neutral |
| 2021-04-09 | Iniziato | Berenberg | Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-02-11 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2021-01-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-09-21 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-07-06 | Reiterato | Needham | Buy |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-04-07 | Iniziato | Northland Capital | Outperform |
| 2020-03-20 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-02-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-01-24 | Iniziato | SunTrust | Buy |
| 2020-01-23 | Iniziato | SunTrust | Buy |
| 2019-11-06 | Iniziato | BTIG Research | Buy |
| 2019-06-11 | Iniziato | Barclays | Overweight |
| 2019-05-06 | Aggiornamento | Mizuho | Underperform → Neutral |
| 2019-05-02 | Aggiornamento | Stifel | Sell → Hold |
| 2019-02-01 | Downgrade | Mizuho | Neutral → Underperform |
| 2018-08-06 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-21 | Reiterato | Mizuho | Neutral |
| 2018-02-16 | Downgrade | Needham | Buy → Hold |
| 2018-01-19 | Iniziato | Seaport Global Securities | Buy |
| 2018-01-04 | Reiterato | Canaccord Genuity | Buy |
| 2018-01-03 | Iniziato | Leerink Partners | Mkt Perform |
Mostra tutto
Pacira Biosciences Inc Borsa (PCRX) Ultime notizie
Automated trading signals detected on Pacira BioSciences Inc.2025 Dividend Review & Real-Time Volume Analysis Alerts - Newser
Predicting Pacira BioSciences Inc. trend using moving averagesJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - Newser
Chart based exit strategy for Pacira BioSciences Inc.Swing Trade & Reliable Intraday Trade Plans - Newser
Is Pacira BioSciences Inc. impacted by rising ratesJuly 2025 Update & Consistent Return Investment Signals - خودرو بانک
Tools to assess Pacira BioSciences Inc.’s risk profileBear Alert & Risk Managed Investment Strategies - Newser
Technical signs of recovery in Pacira BioSciences Inc.Fed Meeting & Comprehensive Market Scan Reports - Newser
Pacira BioSciences: Corporate Governance Reforms and Executive Compensation Alignment in 2025 - AInvest
Does Pacira BioSciences Inc. have strong fundamentalsJuly 2025 Earnings & Fast Moving Trade Plans - خودرو بانک
Pacira BioSciences reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Pacira (PCRX) BioSciences Announces Inducement Awards to New Emp - GuruFocus
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listin - GuruFocus
Pacira BioSciences’ Strategic Use of Equity Incentives to Fuel Growth - AInvest
Pacira BioSciences grants inducement awards to nine new employees. - AInvest
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
31.1K Shares Worth of Equity Awards: Pacira BioSciences Strengthens Team with Nine Strategic Hires - Stock Titan
Visual trend scoring systems applied to Pacira BioSciences Inc.July 2025 Outlook & Consistent Profit Alerts - Newser
Detecting price anomalies in Pacira BioSciences Inc. with AIInflation Watch & Target Return Focused Picks - Newser
Live market analysis of Pacira BioSciences Inc.Treasury Yields & Long-Term Growth Plans - Newser
Trend analysis for Pacira BioSciences Inc. this weekTrade Entry Report & Real-Time Stock Movement Alerts - Newser
Pacira BioSciences Inc. stock prediction for this weekEarnings Recap Report & Entry Point Confirmation Alerts - Newser
Does Pacira BioSciences Inc. have declining or rising EPSJuly 2025 Snapshot & Weekly High Return Stock Forecasts - خودرو بانک
Can Pacira BioSciences Inc. grow without external funding2025 Short Interest & AI Based Buy and Sell Signals - خودرو بانک
Does Pacira BioSciences Inc. fit your quant trading modelWeekly Stock Report & Low Risk High Win Rate Stock Picks - Newser
What are Pacira BioSciences Inc.’s earnings expectationsJuly 2025 PreEarnings & Short-Term High Return Strategies - خودرو بانک
Using flow based indicators on Pacira BioSciences Inc.Market Rally & Fast Exit Strategy with Risk Control - Newser
Best data tools to analyze Pacira BioSciences Inc. stockM&A Rumor & Safe Swing Trade Setups - Newser
Risk adjusted return profile for Pacira BioSciences Inc. analyzedJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser
What data driven models say about Pacira BioSciences Inc.’s future2025 Investor Takeaways & Capital Efficiency Focused Strategies - Newser
Institutional scanner results for Pacira BioSciences Inc.July 2025 Sentiment & AI Driven Stock Price Forecasts - Newser
Exit strategy if you’re trapped in Pacira BioSciences Inc.July 2025 Spike Watch & Precise Swing Trade Entry Alerts - Newser
Pacira BioSciences Inc. stock trend forecastJuly 2025 Big Picture & Low Drawdown Trading Techniques - Newser
Reversal indicators forming on Pacira BioSciences Inc. stockQuarterly Portfolio Summary & Daily Stock Trend Watchlist - Newser
Candlestick signals on Pacira BioSciences Inc. stock todayShare Buyback & Verified Trade Idea Suggestions - Newser
Has Pacira BioSciences Inc. formed a bullish divergenceJuly 2025 Spike Watch & Community Consensus Trade Signals - Newser
Published on: 2025-09-03 02:53:04 - Newser
Is Pacira BioSciences Inc. stock a value trapQuarterly Trade Summary & Consistent Growth Equity Picks - خودرو بانک
Signal strength of Pacira BioSciences Inc. stock in tech scannersEarnings Performance Report & Weekly Sector Rotation Insights - Newser
How to forecast Pacira BioSciences Inc. trends using time seriesJuly 2025 Levels & Risk Controlled Daily Plans - Newser
Will Pacira BioSciences Inc. rebound enough to break evenJuly 2025 Snapshot & High Accuracy Trade Alerts - Newser
Is Pacira BioSciences Inc. subject to activist investor interestPortfolio Update Report & Daily Entry Point Alerts - خودرو بانک
Is Pacira BioSciences Inc. a strong growth stock2025 Volume Leaders & High Yield Equity Trading Tips - خودرو بانک
Risk vs reward if holding onto Pacira BioSciences Inc.Weekly Gains Report & Community Verified Trade Alerts - Newser
Pacira Biosciences Inc Azioni (PCRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):